Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1053655-66-5 | MDL No. : | MFCD10699200 |
Formula : | C6H4BrN3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VGJYOOVSVQHZPL-UHFFFAOYSA-N |
M.W : | 198.02 | Pubchem ID : | 37818533 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 40.69 |
TPSA : | 30.19 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.49 cm/s |
Log Po/w (iLOGP) : | 1.86 |
Log Po/w (XLOGP3) : | 1.44 |
Log Po/w (WLOGP) : | 1.49 |
Log Po/w (MLOGP) : | 1.35 |
Log Po/w (SILICOS-IT) : | 1.2 |
Consensus Log Po/w : | 1.47 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.64 |
Solubility : | 0.453 mg/ml ; 0.00229 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.68 |
Solubility : | 4.14 mg/ml ; 0.0209 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.57 |
Solubility : | 0.533 mg/ml ; 0.00269 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.69 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | Stage #1: With hydrogenchloride In water for 15 h; Reflux Stage #2: With sodium hydrogencarbonate In water |
To compound 18 in 98percent formic acid (12 mL) and water (3 mL), concentrated hydrochloric acid (3 mL) was added and the solution was heated at reflux for 15 hours. Then, the reaction mixture was concentrated under reduced pressure to reduce the volume by half, neutralized with aqueous NaHCO3 and extracted with methanol-chloroform (1:9). After washing with water and drying, the solvent was evaporated. The residue was recrystallized from hexane-chloroform to afford 3.313 g of compound 19 as colorless needle-like crystal. The recrystallization mother liquid was purified by column chromatography (methanol-chloroform (1:19)). Recrystallization from hexane-chloroform afforded 977 mg of compound 19 as colorless needle-like crystal. Total: 4.290 g (84percent).Compound 19: as colorless needle-like crystal mp: 108-108.5° C. (Hexane-CHCl3);1H-NMR (300 MHz, CDCl3) 7.15 (dd, 7, 2, 1H), 7.97 (d, 2, 1H), 8.34 (s, 1H), 8.48 (d, 7, 1H);LRMS m/z 197, 199 (M+, 100, 97), 156, 158 (10, 11), 91(42), 64 (74). |
[ 1159812-31-3 ]
7-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.91
[ 882521-63-3 ]
7-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine
Similarity: 0.91
[ 356560-80-0 ]
6-Bromo-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.91
[ 746668-59-7 ]
6-Bromo-5-methyl[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.88
[ 947248-68-2 ]
6-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine
Similarity: 0.83
[ 1159812-31-3 ]
7-Bromo-2-methyl-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.91
[ 882521-63-3 ]
7-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-amine
Similarity: 0.91
[ 356560-80-0 ]
6-Bromo-[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.91
[ 746668-59-7 ]
6-Bromo-5-methyl[1,2,4]triazolo[1,5-a]pyridine
Similarity: 0.88
[ 274-85-1 ]
[1,2,4]Triazolo[1,5-a]pyridine
Similarity: 0.87